RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Qualigen Therapeutics Stock

Qualigen Therapeutics Debt 2024

Qualigen Therapeutics Debt

0.9 USD

Ticker

QLGN

ISIN

US74754R1032

WKN

A2P5C5

In 2024, Qualigen Therapeutics's total debt was 0.9 USD, a -114.76% change from the -6.08 USD total debt recorded in the previous year.

Qualigen Therapeutics Aktienanalyse

What does Qualigen Therapeutics do?

Qualigen Therapeutics is a company that specializes in the development and production of innovative therapeutics, diagnostics, and medical devices. It was founded in 1995 and has since become a major player in the bio-pharmaceutical industry. The company focuses on the development of oncology products and has expanded its portfolio to include a wide range of products and services for various disease conditions. It markets its products and services through collaborations with institutions and companies worldwide. The company is divided into different divisions, including oncology, infectious diseases, immunology, and metabolic disorders, each offering innovative products and services tailored to specific clinical needs. In the oncology division, Qualigen Therapeutics develops therapeutics for the treatment of cancer, including a novel lung cancer medication. It has also developed a promising therapy for COVID-19. In the infectious diseases division, the company focuses on the development of diagnostics and therapeutics for the treatment of infectious diseases, such as a rapid HIV test and a novel medication for tuberculosis. The immunology division focuses on the development of diagnostics and therapeutics for autoimmune diseases, including a diagnostic test for rheumatoid arthritis and a novel medication for multiple sclerosis. In the metabolic disorders division, the company develops diagnostics and therapeutics for conditions like diabetes, including a diagnostic test for diabetes and a novel medication for obesity. Qualigen Therapeutics is an innovative and forward-thinking company that specializes in the development and production of therapeutics, diagnostics, and medical devices. It collaborates with various institutions and companies worldwide to market its products and services. Its different divisions offer a wide range of innovative products and services tailored to specific clinical needs. Qualigen Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Qualigen Therapeutics's Debt Structure

Qualigen Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Qualigen Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Qualigen Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Qualigen Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Qualigen Therapeutics stock

What is the debt of Qualigen Therapeutics this year?

Qualigen Therapeutics has a debt level of 0.9 USD this year.

What was the debt of Qualigen Therapeutics compared to the previous year?

The debt of Qualigen Therapeutics has increased by -114.76% compared to the previous year dropped.

What are the consequences of high debt for investors in Qualigen Therapeutics?

High debt can pose a risk for investors of Qualigen Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Qualigen Therapeutics?

Low debt means that Qualigen Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Qualigen Therapeutics affect the company?

An increase in debt of Qualigen Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Qualigen Therapeutics affect the company?

A reduction in debt of Qualigen Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Qualigen Therapeutics?

Some factors that can influence the debt of Qualigen Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Qualigen Therapeutics so important for investors?

The debts of Qualigen Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Qualigen Therapeutics take to change the debt?

To change the debt, Qualigen Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Qualigen Therapeutics pay?

Over the past 12 months, Qualigen Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qualigen Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Qualigen Therapeutics?

The current dividend yield of Qualigen Therapeutics is .

When does Qualigen Therapeutics pay dividends?

Qualigen Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qualigen Therapeutics?

Qualigen Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Qualigen Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qualigen Therapeutics located?

Qualigen Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Qualigen Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qualigen Therapeutics from 11/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Qualigen Therapeutics pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Qualigen Therapeutics in the year 2023?

In the year 2023, Qualigen Therapeutics distributed 0 USD as dividends.

In which currency does Qualigen Therapeutics pay out the dividend?

The dividends of Qualigen Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qualigen Therapeutics

Our stock analysis for Qualigen Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qualigen Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.